News

The World Health Organization (WHO) has reinforced its support to Tanzania’s post-Marburg Virus Disease (MVD) recovery by ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
The World Health Organization (WHO), has raised the alarm that Nigeria loses about $1.2billion yearly from its economy to ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
In 2024, 89% of infants globally—about 115 million—received at least one dose of the diphtheria, tetanus, and pertussis (DTP) ...
Venus Remedies secures WHO GDP endorsement for best-in-class pharma logistics: Our Bureau, Bengaluru Friday, July 18, 2025, 12:20 Hrs [IST] Venus Remedies, a leading research-driv ...
- Recognized for its expertise in health surveillance, KDCA has been designated as the ‘WHO Collaborating Center for NCD Surveillance and Bigdata Utilization.” - KDCA will continue to take part in ...
Uganda strengthens border health amid ongoing threats Health | AGENCIES | Uganda’s borders have always been busy and ...
An international research team has investigated the physical activity behavior of study participants from Berlin's inner-city ...
Soft tissue cytopathology plays a vital role in the diagnosis and management of soft tissue neoplasms, necessitating a standardized classification ...
TANZANIA is among countries expected to benefit from the upcoming rollout of injectable lenacapavir for HIV prevention, following a landmark recommendation by the World Health Organization (WHO).
The World Health Organization on Wednesday called on more countries to accept and treat patients from the Gaza Strip after ...